| Literature DB >> 34211176 |
Joel Gelernter1,2, Renato Polimanti3,4.
Abstract
Substance use disorders (SUDs) are conditions in which the use of legal or illegal substances, such as nicotine, alcohol or opioids, results in clinical and functional impairment. SUDs and, more generally, substance use are genetically complex traits that are enormously costly on an individual and societal basis. The past few years have seen remarkable progress in our understanding of the genetics, and therefore the biology, of substance use and abuse. Various studies - including of well-defined phenotypes in deeply phenotyped samples, as well as broadly defined phenotypes in meta-analysis and biobank samples - have revealed multiple risk loci for these common traits. A key emerging insight from this work establishes a biological and genetic distinction between quantity and/or frequency measures of substance use (which may involve low levels of use without dependence), versus symptoms related to physical dependence.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34211176 PMCID: PMC9210391 DOI: 10.1038/s41576-021-00377-1
Source DB: PubMed Journal: Nat Rev Genet ISSN: 1471-0056 Impact factor: 59.581